CTBP1-AS

Across TCGA pan-cancer cohorts, CTBP1-AS RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated CTBP1-AS data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher CTBP1-AS RNA is associated with better overall survival. In most high-consensus cancer types, elevated CTBP1-AS expression acts as an unfavorable survival marker, although some lineages such as HNSC and SKCM show a favorable association.

HNSC, SKCM, and UVM are the cancer types where CTBP1-AS RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	All	0.528	0.318	<.001	123	view →
SKCM	OS	Tertile	III,IV	0.529	0.259	.002	59	view →
UVM	DFS	Quartile	III,IV	0.171	0.893	<.001	56	view →
UCS	DFS	Median	IV	0.952	0.367	.001	52	view →
PAAD	OS	Median	All	0.513	0.280	<.001	48	view →
CESC	DFS	Median	All	0.669	0.810	.004	36	view →
OV	OS	Median	IV	0.602	0.883	.003	32	view →
LGG	DFS	Median	All	0.780	0.883	<.001	30	view →
KIRP	DFS	Tertile	IV	0.043	0.811	.010	29	view →
BRCA	OS	Quartile	III,IV	0.950	0.788	.003	26	view →
KIRC	DFS	Median	All	0.567	0.675	.009	25	view →
BLCA	OS	Quartile	II,III,IV	0.783	0.654	.022	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

CTBP1-AS–HNSC (OS)

Open the HNSC breakdown →